{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:52:17Z","timestamp":1767833537939,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009874","name":"Universit\u00e9 de Sherbrooke","doi-asserted-by":"publisher","award":["2022-3652"],"award-info":[{"award-number":["2022-3652"]}],"id":[{"id":"10.13039\/100009874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-21015\\u201303671"],"award-info":[{"award-number":["RGPIN-21015\\u201303671"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2015\\u201303671"],"award-info":[{"award-number":["RGPIN-2015\\u201303671"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2024\\u201304744"],"award-info":[{"award-number":["RGPIN-2024\\u201304744"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.112166","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T21:30:45Z","timestamp":1714253445000},"page":"112166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Stat5b\/Ezh2 axis governs high PD-L1 expressing tolerogenic dendritic cell subset in autoimmune diabetes"],"prefix":"10.1016","volume":"133","author":[{"given":"Farhan","family":"Ullah Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puregmaa","family":"Khongorzul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Gris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8092-0824","authenticated-orcid":false,"given":"Abdelaziz","family":"Amrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112166_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.889856","article-title":"Genetic Modifiers of thymic selection and central tolerance in type 1 diabetes","volume":"13","author":"Kissler","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112166_b0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007807","article-title":"Breakdown in peripheral tolerance in type 1 diabetes in mice and humans","volume":"2","author":"Jeker","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9","key":"10.1016\/j.intimp.2024.112166_b0015","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.3390\/ijms23094885","article-title":"Dendritic cells and their immunotherapeutic potential for treating type 1 diabetes","volume":"23","author":"Khan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112166_b0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-075049","article-title":"The varieties of immunological experience: of pathogens, stress, and dendritic cells","volume":"33","author":"Pulendran","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112166_b0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1189\/jlb.3MR1115-500R","article-title":"Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment","volume":"100","author":"Hotta-Iwamura","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.intimp.2024.112166_b0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2016.09.001","article-title":"Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression","volume":"76","author":"Zerif","year":"2017","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.intimp.2024.112166_b0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/intimm\/dxs006","article-title":"Enumeration of human peripheral blood dendritic cells throughout the life","volume":"24","author":"Orsini","year":"2012","journal-title":"Int. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2024.112166_b0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112166_b0045","series-title":"Advances in Immunology","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/B978-0-12-417028-5.00009-0","article-title":"Chapter Nine - Transcriptional Control of Dendritic Cell Development","author":"Murphy","year":"2013"},{"issue":"17","key":"10.1016\/j.intimp.2024.112166_b0050","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.3390\/cells11172630","article-title":"IRF8: mechanism of action and health implications","volume":"11","author":"Moorman","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2024.112166_b0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41385-020-0276-8","article-title":"\u03b1v\u03b28 integrin-expression by BATF3-dependent dendritic cells facilitates early IgA responses to Rotavirus","volume":"14","author":"Nakawesi","year":"2021","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.intimp.2024.112166_b0060","article-title":"IRF8-dependent type I conventional dendritic cells (cDC1s) control post-ischemic inflammation and mildly protect against post-ischemic acute kidney injury and disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.intimp.2024.112166_b0065","article-title":"IRF4 expression by lung dendritic cells drives acute but not Trm cell-dependent memory Th2 responses. JCI","volume":"7","author":"Camacho","year":"2022","journal-title":"Insight"},{"issue":"5","key":"10.1016\/j.intimp.2024.112166_b0070","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.immuni.2015.04.017","article-title":"Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses","volume":"42","author":"Tussiwand","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112166_b0075","doi-asserted-by":"crossref","first-page":"e49416","DOI":"10.7554\/eLife.49416","article-title":"Inhibition of IRF4 in dendritic cells by PRR-independent and -dependent signals inhibit Th2 and promote Th17 responses","volume":"9","author":"Lee","year":"2020","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.intimp.2024.112166_b0080","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.immuni.2016.02.008","article-title":"IRF8 transcription-factor-dependent classical dendritic cells are essential for intestinal T cell homeostasis","volume":"44","author":"Luda","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2024.112166_b0085","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.4049\/jimmunol.1501870","article-title":"IRF4 and IRF8 Act in CD11c+ Cells To regulate terminal differentiation of lung tissue dendritic cells","volume":"196","author":"Baja\u00f1a","year":"2016","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112166_b0090","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.immuni.2013.04.011","article-title":"IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses","volume":"38","author":"Schlitzer","year":"2013","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.intimp.2024.112166_b0095","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.immuni.2013.03.009","article-title":"IRF4 transcription-factor-dependent CD103+ CD11b+ dendritic cells drive mucosal T helper 17 cell differentiation","volume":"38","author":"Persson","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2024.112166_b0100","first-page":"29","article-title":"Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice","volume":"13","author":"Boudaly","year":"2002","journal-title":"Eur. Cytokine Netw."},{"issue":"5","key":"10.1016\/j.intimp.2024.112166_b0105","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.4049\/jimmunol.0803543","article-title":"Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues1","volume":"182","author":"Melli","year":"2009","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112166_b0110","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1074\/jbc.M312110200","article-title":"A mutant Stat5b with weaker DNA binding affinity defines a key defective pathway in nonobese diabetic mice","volume":"279","author":"Davoodi-Semiromi","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.intimp.2024.112166_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186453","article-title":"Elucidating the role of Ezh2 in tolerogenic function of NOD bone marrow-derived dendritic cells expressing constitutively active Stat5b","volume":"21","author":"Zerif","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.112166_b0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.immuni.2016.07.017","article-title":"Programmed death-1 ligand 2-mediated regulation of the PD-L1 to PD-1 axis is essential for establishing CD4+ T Cell immunity","volume":"45","author":"Karunarathne","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2024.112166_b0125","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1038\/s41467-022-32899-5","article-title":"PD-L2 controls peripherally induced regulatory T cells by maintaining metabolic activity and Foxp3 stability","volume":"13","author":"Hurrell","year":"2022","journal-title":"Nat. Commun."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2024.112166_b0130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12026-011-8217-y","article-title":"Dendritic cells and the maintenance of self-tolerance","volume":"50","author":"Morel","year":"2011","journal-title":"Immunol. Res."},{"issue":"16","key":"10.1016\/j.intimp.2024.112166_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168415","article-title":"Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity","volume":"22","author":"Passeri","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2024.112166_b0140","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.intimp.2024.112166_b0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.immuni.2016.07.017","article-title":"Programmed death-1 ligand 2-mediated regulation of the PD-L1 to PD-1 axis is essential for establishing CD4(+) T cell immunity","volume":"45","author":"Karunarathne","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112166_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01710","article-title":"PD-L1 Is expressed and promotes the expansion of regulatory T cells in acute myeloid leukemia","volume":"11","author":"Dong","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112166_b0155","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/eji.201444778","article-title":"Differential control of CD4+ T-cell subsets by the PD-1\/PD-L1 axis in a mouse model of allergic asthma","volume":"45","author":"McAlees","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112166_b0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00251-023-01307-7","article-title":"Dysregulated PD-L2 is correlated with disease activity and inflammation in rheumatoid arthritis","volume":"75","author":"Xiong","year":"2023","journal-title":"Immunogenetics"},{"key":"10.1016\/j.intimp.2024.112166_b0165","article-title":"PD-1\/PD-L1 inhibitors in patients with preexisting autoimmune diseases","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112166_b0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/mi.2009.112","article-title":"PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions","volume":"3","author":"Akbari","year":"2010","journal-title":"Mucosal. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112166_b0175","doi-asserted-by":"crossref","first-page":"e82480","DOI":"10.1371\/journal.pone.0082480","article-title":"TLR2 directing PD-L2 expression inhibit T cells response in schistosoma japonicum infection","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.intimp.2024.112166_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/cells7120256","article-title":"Role of the p38 MAPK\/C\/EBP\u03b2 pathway in the regulation of phenotype and IL-10 and IL-12 production by tolerogenic bone marrow-derived dendritic cells","volume":"7","author":"Guindi","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.112166_b0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.trsl.2022.11.005","article-title":"Inhibition of PI3K\/C\/EBP\u03b2 axis in tolerogenic bone marrow-derived dendritic cells of NOD mice promotes Th17 differentiation and diabetes development","volume":"255","author":"Guindi","year":"2023","journal-title":"Transl. Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.112166_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112166_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00140","article-title":"Interferon-\u03b3 Receptor Signaling in Dendritic Cells Restrains Spontaneous Proliferation of CD4+ T Cells in Chronic Lymphopenic Mice","volume":"10","author":"Knop","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112166_b0200","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","article-title":"Intricacies of TGF-\u03b2 signaling in Treg and Th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.112166_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106275","article-title":"Recent discoveries in dendritic cell tolerance-inducing pharmacological molecules","volume":"81","author":"\u0160vajger","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112166_b0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41565-020-00810-2","article-title":"Inducing immune tolerance with dendritic cell-targeting nanomedicines","volume":"16","author":"Cifuentes-Rius","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112166_b0215","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.immuni.2008.02.013","article-title":"The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8","volume":"28","author":"Esashi","year":"2008","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.intimp.2024.112166_b0220","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.4049\/jimmunol.180.9.5898","article-title":"Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells","volume":"180","author":"Sebasti\u00e1n","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112166_b0225","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1038\/ncomms3990","article-title":"Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation","volume":"4","author":"Williams","year":"2013","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2024.112166_b0230","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/stem.2565","article-title":"Modelling IRF8 deficient human hematopoiesis and dendritic cell development with engineered iPS cells","volume":"35","author":"Sontag","year":"2017","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.intimp.2024.112166_b0235","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.immuni.2016.08.013","article-title":"IRF8 transcription factor controls survival and function of terminally differentiated conventional and plasmacytoid dendritic cells respectively","volume":"45","author":"Sichien","year":"2016","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.intimp.2024.112166_b0240","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1073\/pnas.1722043115","article-title":"B7\u2013H1 maintains the polyclonal T cell response by protecting dendritic cells from cytotoxic T lymphocyte destruction","volume":"115","author":"Chen","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"10.1016\/j.intimp.2024.112166_b0245","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1038\/s41467-020-18570-x","article-title":"PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2024.112166_b0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41392-020-00252-1","article-title":"The role of histone methylation in the development of digestive cancers: a potential direction for cancer management","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2024.112166_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108612","article-title":"EZH2-mediated H3K27me3 promotes autoimmune hepatitis progression by regulating macrophage polarization","volume":"106","author":"Chi","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112166_b0260","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1038\/s41467-023-40186-0","article-title":"Ezh2 emerges as an epigenetic checkpoint regulator during monocyte differentiation limiting cardiac dysfunction post-MI","volume":"14","author":"Rondeaux","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2024.112166_b0265","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4049\/jimmunol.1701470","article-title":"EZH2 represses the B Cell transcriptional program and regulates antibody-secreting cell metabolism and antibody production","volume":"200","author":"Guo","year":"2018","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112166_b0270","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.3390\/ijms24065363","article-title":"The regulatory roles of Ezh2 in response to lipopolysaccharide (LPS) in macrophages and mice with conditional Ezh2 deletion with LysM-Cre system","volume":"24","author":"Kunanopparat","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2024.112166_b0275","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.immuni.2022.06.006","article-title":"IRF8 deficiency induces the transcriptional, functional, and epigenetic reprogramming of cDC1 into the cDC2 lineage","volume":"55","author":"Lanca","year":"2022","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2024.112166_b0280","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.athoracsur.2018.08.056","article-title":"A positive correlation between the EZH2 and PD-L1 expression in resected lung adenocarcinomas","volume":"107","author":"Toyokawa","year":"2019","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.intimp.2024.112166_b0285","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbrc.2019.07.039","article-title":"EZH2 regulates PD-L1 expression via HIF-1alpha in non-small cell lung cancer cells","volume":"517","author":"Zhao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2024.112166_b0290","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s40425-019-0784-9","article-title":"EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma","volume":"7","author":"Xiao","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.intimp.2024.112166_b0295","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1189\/jlb.0406246","article-title":"IRF-1 deficiency skews the differentiation of dendritic cells toward plasmacytoid and tolerogenic features","volume":"80","author":"Gabriele","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"61","key":"10.1016\/j.intimp.2024.112166_b0300","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg3570","article-title":"NF-kappaB-dependent IRF1 activation programs cDC1 dendritic cells to drive antitumor immunity","volume":"6","author":"Ghislat","year":"2021","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112166_b0305","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.intimp.2015.02.010","article-title":"Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer","volume":"25","author":"Zhao","year":"2015","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T20:10:42Z","timestamp":1715631042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924006842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":61,"alternative-id":["S1567576924006842"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112166","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stat5b\/Ezh2 axis governs high PD-L1 expressing tolerogenic dendritic cell subset in autoimmune diabetes","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112166"}}